Sleepy Time Essential Oil Blend
Natural health product licensed in Canada
- Other names
- Sleepy Time 12 ml
- Licence holder
- Essential Nature Inc.
- NPN or DIN-HM
- 80083556
- Status
- Active licence
- Licence date
- 5 March 2018
- Revision date
- Not provided
- Form
- Liquides
- Route of administration
- Inhalation
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Lavandula angustifolia Source : Sommité en fleurs (herbe) | 50.5 % |
| Matricaria chamomilla Source : Fleur | 2.5 % |
| Origanum majorana Source : Herb flowering | 17.5 % |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Goutte(s) ; maximum: 10 Goutte(s) | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Used in aromatherapy as a calmative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if pregnant or breastfeeding.
- Effets indésirables connus
If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
- Précautions et mises en garde
If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Centre. Keep out of reach of children. If symptoms persist or worsen, consult a health care practitioner. If you have epilepsy or asthma, consult a health care practitioner prior to use. Do not expose the applied area to the sun for 24 to 48 hours after application. If you have broken, irritated or sensitive skin, do not use this product.
Source
Official Health Canada record, licence 80083556
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.